Showing results (691-700 of 1,524) with videos related to

Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|September 23, 2024
The population pharmacokinetics of dolutegravir co-administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimensBaralee Punyawudho, Anan Chanruang, Thornthun Ueaphongsukkit, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 3, 2024
PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first-pass metabolism?Justine Henriot, André Dallmann, François Dupuis, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 2, 2024
Interim analysis, a tool to enhance efficiency of pharmacokinetic studies: Pharmacokinetics of rifampicin in lactating mother-infant pairsAida N Kawuma, Francis Williams Ojara, Allan Buzibye, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 16, 2024
Mechanistic pharmacokinetic-pharmacodynamic modeling and simulations of naloxone auto-injector 10 mg reversal of opioid-induced respiratory depressionTae Eun Yang, Francesca Del Bene, Silvia Maria Lavezzi, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 11, 2024
A model-based approach using GSK3772847, an anti-interleukin-33 receptor monoclonal antibody, as a showcase to predict SC administration PK and free target dynamics based on PK and total target measurements after IV administrationJan Berkhout, Dave Fairman, Martijn van Noort, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 16, 2024
A tutorial on physiologically based pharmacokinetic approaches in lactation researchAmita Pansari, Xian Pan, Lisa M Almond, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 23, 2026
Integrating B Cell Differentiation Model With Real-World Data Informs Determinants for Antibody-Secreting Cell Depletions in Systemic SclerosisTomohisa Nakada, Ryuta Saito, Sho Ishigaki, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 26, 2026
Population Pharmacokinetics and Exposure-Response Analyses for Telisotuzumab Vedotin in Patients With c-Met Protein Overexpressing TumorsHeiko Babel, Priya Brunsdon, Benjamin Engelhardt, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 26, 2026
Model-Informed Dosing Regimen of Sugemalimab for European Patients With Non-Small Cell Lung Cancer: Bridging From Asian Clinical DataYucheng Sheng, Zenglian Yue, Fengyan Xu, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 12, 2024
Local depletion of large molecule drugs due to target binding in tissue interstitial spaceTatiana Zasedateleva, Stephan Schaller, Elizabeth C M de Lange, et al.
Pageof 153